Pilot Projects Program
试点项目计划
基本信息
- 批准号:8948616
- 负责人:
- 金额:$ 55.77万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-07-01 至 2021-04-30
- 项目状态:已结题
- 来源:
- 关键词:Academic Medical CentersAdvanced DevelopmentAdvisory CommitteesAreaAttentionAwardBasic ScienceCaringCenters of Research ExcellenceClinical ResearchClinical SciencesClinical TrialsCollaborationsCommunitiesDataDevelopmentDisciplineFundingGrantGrant ReviewGrowthHealth PolicyHospitalsInstitutionLongevityMentorsMethodologyNew EnglandPilot ProjectsPositioning AttributePreparationProcessPublic HealthResearchResearch PersonnelRhode IslandSeriesSiteSystemTestingTranslational ResearchUnited States National Institutes of HealthUniversitiesUniversity HospitalsVeteransWorkabstractingbaseexperiencehealth disparityinterdisciplinary collaborationmeetingsprogramsresponsesymposiumtraining opportunity
项目摘要
ABSTRACT – PILOT PROJECTS PROGRAM
Advancing the development of clinical and translational research in Rhode Island is a critical need. Rhode
Island institutions have a tradition of providing Pilot Projects support, but these awards have generally not been
designated to support clinical and translational research. Thus, there is an unmet need to enhance funding of
Clinical and Translational Research in Rhode Island that would be met by the RI-CCTS. We propose
establishment of a Pilot Project Grants Program that is trans-disciplinary and translational with the following
Specific Aims: 1. Enhance the quality and quantity of clinical and translational research in Rhode
Island by funding Pilot Projects spanning the research spectrum from T1 to T4 and by developing
clinical and translational research collaborations of co-PI's. 2. Promote selected high impact clinical
and translational research areas via Emerging Areas of Research Symposia at institutions in Rhode
Island, in collaboration with existing INBRE and COBRE programs. In the Pilot Projects Program, junior
investigators (or more senior investigators transitioning to a translational research focus) will have the
opportunity to apply for small grants of one year duration with an option of applying for a second year. In order
to stimulate interdisciplinary collaboration, each Pilot Project grant will have two co-PI's from different
disciplines. Two senior investigators will be designated as mentors to advise on grant preparation and conduct
of the research. One mentor will have specific background in methodology or basic science, and the other
mentor will have clinical science expertise. At least one of the Pilot Projects awarded through the RI-CCTS
each year will include a clinical trial. In order to stimulate Clinical and Translational Research in high impact
areas, the Pilot Projects Program Advisory Committee will work with the IDeA programs funded in RI to
develop an annual research symposium on relevant topics. Symposia sites will rotate among Brown University,
the Affiliated Hospitals, and the University of Rhode Island. The Pilot Projects Program will be led by Sharon
Rounds with Deputy Leader Michelle Lally. It will be supported by an Advisory Committee that includes
representatives from the Lifespan and Care New England Hospital Systems, the Providence Veterans Affairs
Medical Center, the University of Rhode Island, and Brown University. The Advisory Committee will oversee
application and review processes and, in conjunction with the RI-CCTS Internal Advisory Committee (IAC), will
determine prioritization of research topics. Particular attention will be paid to support of clinical and
translational research in areas of health disparities in Rhode Island. The Pilot Projects Program will leverage
professional development opportunities, functionality and facilities offered by other Key Components (KC) of
the RI-CCTS. The Pilot Projects Program will be an integral part of the RI-CCTS, providing opportunities to
perform collaborative Clinical and Translational Research and to interact with other investigators to stimulate
new research.
摘要 – 试点项目计划
推动罗德岛州临床和转化研究的发展是一项迫切需要。罗德
岛屿机构有提供试点项目支持的传统,但这些奖项通常没有得到认可。
指定用于支持临床和转化研究。因此,增加资金投入的需求尚未得到满足。
罗德岛州的临床和转化研究将由 RI-CCTS 负责。我们建议
建立一个跨学科和转化性的试点项目资助计划,其中包括以下内容
具体目标: 1. 提高罗德岛临床和转化研究的质量和数量
岛通过资助涵盖从 T1 到 T4 研究范围的试点项目并开发
共同 PI 的临床和转化研究合作。 2. 促进选定的高影响力临床
和转化研究领域,通过罗德岛机构的新兴研究领域研讨会
Island,与现有的 INBRE 和 COBRE 项目合作。在试点项目计划中,初级
研究人员(或更高级的研究人员转向转化研究重点)将拥有
有机会申请为期一年的小额赠款,并可以选择申请第二年。为了
为了促进跨学科合作,每个试点项目拨款将有来自不同领域的两名联合 PI
学科。两名高级研究员将被指定为导师,就拨款准备和实施提供建议
研究的。一位导师将具有方法论或基础科学的特定背景,另一位导师将具有方法论或基础科学的特定背景
导师将具有临床科学专业知识。至少一个通过 RI-CCTS 授予的试点项目
每年都会包括一项临床试验。为了促进高影响力的临床和转化研究
领域,试点项目计划咨询委员会将与 RI 资助的 IDeA 计划合作,
举办有关相关主题的年度研究研讨会。研讨会地点将在布朗大学、
附属医院和罗德岛大学。试点项目计划将由沙龙领导
与副党魁米歇尔·拉利 (Michelle Lally) 会面。它将得到咨询委员会的支持,其中包括
来自新英格兰生命与护理医院系统、普罗维登斯退伍军人事务部的代表
医学中心、罗德岛大学和布朗大学。咨询委员会将监督
申请和审查流程,并与 RI-CCTS 内部咨询委员会 (IAC) 一起,
确定研究课题的优先顺序。将特别关注临床和
罗德岛州健康差异领域的转化研究。试点项目计划将利用
其他关键组件 (KC) 提供的专业发展机会、功能和设施
RI-CCTS。试点项目计划将成为 RI-CCTS 的一个组成部分,为
进行协作临床和转化研究并与其他研究人员互动以刺激
新的研究。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sharon Irene Smith Rounds其他文献
Sharon Irene Smith Rounds的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Sharon Irene Smith Rounds', 18)}}的其他基金
RI-Center for Clinical and Translational Science
RI-临床和转化科学中心
- 批准号:
10413517 - 财政年份:2021
- 资助金额:
$ 55.77万 - 项目类别:
Advance Clinical and Translational Research (Advance-CTR)
高级临床和转化研究(Advance-CTR)
- 批准号:
10468390 - 财政年份:2021
- 资助金额:
$ 55.77万 - 项目类别:
Advance Clinical and Translational Research (Advance-CTR)
高级临床和转化研究(Advance-CTR)
- 批准号:
10681738 - 财政年份:2021
- 资助金额:
$ 55.77万 - 项目类别:
RI-Center for Clinical and Translational Science
RI-临床和转化科学中心
- 批准号:
10403751 - 财政年份:2016
- 资助金额:
$ 55.77万 - 项目类别:
Advance Clinical and Translational Research (Advance-CTR)
高级临床和转化研究(Advance-CTR)
- 批准号:
10595415 - 财政年份:2016
- 资助金额:
$ 55.77万 - 项目类别:
Advance Clinical and Translational Research (Advance-CTR)
高级临床和转化研究(Advance-CTR)
- 批准号:
10281523 - 财政年份:2016
- 资助金额:
$ 55.77万 - 项目类别:
Advance Clinical and Translational Research (Advance-CTR)
高级临床和转化研究(Advance-CTR)
- 批准号:
10466949 - 财政年份:2016
- 资助金额:
$ 55.77万 - 项目类别:
Advance Clinical and Translational Research (Advance-CTR)
高级临床和转化研究(Advance-CTR)
- 批准号:
10726129 - 财政年份:2016
- 资助金额:
$ 55.77万 - 项目类别:
相似海外基金
ADVANCED DEVELOPMENT OF LQ A LIPOSOME-BASED SAPONIN-CONTAINING ADJUVANT FOR USE IN PANSARBECOVIRUS VACCINES
用于 Pansarbecovirus 疫苗的 LQ A 脂质体含皂苷佐剂的先进开发
- 批准号:
10935820 - 财政年份:2023
- 资助金额:
$ 55.77万 - 项目类别:
ADVANCED DEVELOPMENT OF BBT-059 AS A RADIATION MEDICAL COUNTERMEASURE FOR DOSING UP TO 48H POST EXPOSURE"
BBT-059 的先进开发,作为辐射医学对策,可在暴露后 48 小时内进行给药”
- 批准号:
10932514 - 财政年份:2023
- 资助金额:
$ 55.77万 - 项目类别:
Advanced Development of a Combined Shigella-ETEC Vaccine
志贺氏菌-ETEC 联合疫苗的先进开发
- 批准号:
10704845 - 财政年份:2023
- 资助金额:
$ 55.77万 - 项目类别:
Advanced development of composite gene delivery and CAR engineering systems
复合基因递送和CAR工程系统的先进开发
- 批准号:
10709085 - 财政年份:2023
- 资助金额:
$ 55.77万 - 项目类别:
Advanced development and validation of an in vitro platform to phenotype brain metastatic tumor cells using artificial intelligence
使用人工智能对脑转移肿瘤细胞进行表型分析的体外平台的高级开发和验证
- 批准号:
10409385 - 财政年份:2022
- 资助金额:
$ 55.77万 - 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES
针对大流行和突发冠状病毒的疫苗的高级开发
- 批准号:
10710595 - 财政年份:2022
- 资助金额:
$ 55.77万 - 项目类别:
Advanced development and validation of an in vitro platform to phenotype brain metastatic tumor cells using artificial intelligence
使用人工智能对脑转移肿瘤细胞进行表型分析的体外平台的高级开发和验证
- 批准号:
10630975 - 财政年份:2022
- 资助金额:
$ 55.77万 - 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE CANDIDATE FOR STAPHYLOCOCCUS AUREUS INFECTION
金黄色葡萄球菌感染候选疫苗的高级开发
- 批准号:
10710588 - 财政年份:2022
- 资助金额:
$ 55.77万 - 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES
针对大流行和突发冠状病毒的疫苗的高级开发
- 批准号:
10788051 - 财政年份:2022
- 资助金额:
$ 55.77万 - 项目类别:














{{item.name}}会员




